company background image
VDP logo

Vidipha Central Pharmaceutical HOSE:VDP Stock Report

Last Price

₫39.90k

Market Cap

₫734.3b

7D

-0.3%

1Y

5.8%

Updated

25 Apr, 2024

Data

Company Financials

Vidipha Central Pharmaceutical Joint Stock Company

HOSE:VDP Stock Report

Market Cap: ₫734.3b

VDP Stock Overview

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand.

VDP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Vidipha Central Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vidipha Central Pharmaceutical
Historical stock prices
Current Share Price₫39,900.00
52 Week High₫42,800.00
52 Week Low₫32,650.00
Beta0
1 Month Change-3.39%
3 Month Change7.84%
1 Year Change5.84%
3 Year Change8.72%
5 Year Change20.00%
Change since IPO17.53%

Recent News & Updates

Recent updates

Shareholder Returns

VDPVN PharmaceuticalsVN Market
7D-0.3%-1.3%1.0%
1Y5.8%15.7%14.9%

Return vs Industry: VDP underperformed the VN Pharmaceuticals industry which returned 15.7% over the past year.

Return vs Market: VDP underperformed the VN Market which returned 14.9% over the past year.

Price Volatility

Is VDP's price volatile compared to industry and market?
VDP volatility
VDP Average Weekly Movement8.5%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement4.7%
10% most volatile stocks in VN Market7.0%
10% least volatile stocks in VN Market2.4%

Stable Share Price: VDP has not had significant price volatility in the past 3 months.

Volatility Over Time: VDP's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of VN stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aHoa Van Hoangwww.vidipha.com.vn

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. The company primarily provides antibiotics, anti-inflammatory, vitamins and mineral salts, pain relievers, antipyretics, anti-allergy drugs, and other medicines for the treatment of worm, fluke, respiratory, gastrointestinal, and skin diseases. It offers its products in the form of compress and capsule Pills, Powdered granules, powder and liquid Injections, Syrups, drinking tubes, Eye and nose drops, Topical creams, and ointments.

Vidipha Central Pharmaceutical Joint Stock Company Fundamentals Summary

How do Vidipha Central Pharmaceutical's earnings and revenue compare to its market cap?
VDP fundamental statistics
Market cap₫734.28b
Earnings (TTM)₫0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VDP income statement (TTM)
Revenue₫0
Cost of Revenue₫0
Gross Profit₫0
Other Expenses₫0
Earnings₫0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did VDP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.